CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | Scadden David Director | Option exercise · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | Scadden David Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | Scadden David Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2026-06-18 | Smith Cynthia Director | Option exercise | +2,816 | 15,230 | ||
| 2026-06-18 | Smith Cynthia Director | Option exercise · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | Smith Cynthia Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | Smith Cynthia Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2026-06-18 | Viswanadhan Krishnan Chief Strategy and Operations | Option exercise · Performance share units | −3,000 | 9,000 | ||
| 2026-06-18 | Viswanadhan Krishnan Chief Strategy and Operations | Grant or award · Restricted stock units | +3,000 | 3,000 | ||
| 2026-06-18 | Goff Brian Chief Executive Officer | Option exercise · Performance share units | −39,000 | 39,000 | ||
| 2026-06-18 | Goff Brian Chief Executive Officer | Grant or award · Restricted stock units | +39,000 | 39,000 | ||
| 2026-06-18 | Burns James William Chief Legal Officer | Option exercise · Performance share units | −3,000 | 9,000 | ||
| 2026-06-18 | Burns James William Chief Legal Officer | Grant or award · Restricted stock units | +3,000 | 3,000 | ||
| 2026-06-18 | Gheuens Sarah Chief Medical Officer | Option exercise · Performance share units | −3,000 | 9,000 | ||
| 2026-06-18 | Gheuens Sarah Chief Medical Officer | Grant or award · Restricted stock units | +3,000 | 3,000 | ||
| 2026-06-18 | Jones Cecilia Chief Financial Officer | Option exercise · Performance share units | −3,000 | 9,000 | ||
| 2026-06-18 | Jones Cecilia Chief Financial Officer | Grant or award · Restricted stock units | +3,000 | 3,000 | ||
| 2026-06-18 | Milanova Tsveta Chief Commercial Officer | Option exercise · Performance share units | −3,000 | 9,000 | ||
| 2026-06-18 | Milanova Tsveta Chief Commercial Officer | Grant or award · Restricted stock units | +3,000 | 3,000 | ||
| 2026-06-18 | Backstrom Jay T. Director | Grant or award · Restricted stock units | +2,927 | 2,927 |
Page 3 of 48 · 941 trades